- Huntington disease and Beta-blocker drug use
- Innovative Interventions: Postbiotics and Psychobiotics in Neurodegenerative Disease Treatment
- In Vitro Efficacy of PEI-Derived Lipopolymers in Silencing of Toxic Proteins in a Neuronal Model of Huntington's Disease
- Multitarget Compounds Designed for Alzheimer, Parkinson, and Huntington Neurodegeneration Diseases
- A lysosomal surveillance response to stress extends healthspan
- The Retinal Dopaminergic Circuit as a Biomarker for Huntington's and Alzheimer's Diseases
- Cortical and Striatal Functional Connectivity in Juvenile-Onset Huntington's Disease
- Oxidative Stress: Pathological Driver in Chronic Neurodegenerative Diseases
- An Updated and Comprehensive Review Exploring the Gut-Brain Axis in Neurodegenerative Disorders and Neurotraumas: Implications for Therapeutic Strategies
- Pharmacological and Pathological Implications of Sigma-1 Receptor in Neurodegenerative Diseases
- Complex cognitive and motivational deficits precede motor dysfunction in the zQ175 (190 CAG repeat) Huntington's disease model
- Interplay between Exercise and Neuregulin in providing neuroprotection
- Decoding Huntington's disease: a global survey on symptoms and genetic testing practices
- Two Decades of Huntington's Disease in Varna, Bulgaria: A Retrospective Single-Centre Study of Clinical Trends and Challenges
- Modulating Cognition-Linked Histone Acetyltransferases (HATs) as a Therapeutic Strategy for Neurodegenerative Diseases: Recent Advances and Future Trends
- Blocking somatic repeat expansion and lowering huntingtin via RNA interference synergize to prevent Huntingtons disease pathogenesis in mice
- Optogenetics to Biomolecular Phase Separation in Neurodegenerative Diseases
- Time to retire the term "atypical Parkinsonism"
- Unveiling mysteries of aging: the potential of melatonin in preventing neurodegenerative diseases in older adults
- The role of Poly-ADP ribose polymerase (PARP) enzymes in chemotherapy-induced cognitive impairments - parallels with other neurodegenerative disorders
- Adult-onset Huntington's disease with unusual presentation of dopa-responsive lower limb dystonia
- Allelic Diversity, De Novo CAG Expansions and Intergenerational Instability at the HTT Locus in a Sample from India
- Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders
- Cell membrane-coated nanoparticles in neurodegenerative disorders management
- Increased Activity-Dependent Bulk Endocytosis in Huntington's Disease Results From Huntingtin Haploinsufficiency
- Intersection of H<sub>2</sub>S and Nrf2 signaling: Therapeutic opportunities for neurodegenerative diseases
- Concomitant pathologies and their impact on Huntington's disease. A brief review of current evidence
- Epigenetic reprogramming as a therapeutic strategy for neurodegenerative diseases: A complex and novel approach
- NKX2-5 congenital heart disease mutations show diverse loss and gain of epigenomic, biochemical and chromatin search functions underpinning pathogenicity
- Synaptic mitochondria in aging and neurodegenerative diseases: unraveling their functional decline and vulnerability
- DNAJB6: A guardian against neurodegeneration
- Neuroglobin: A promising candidate to treat neurological diseases
- Mitochondrial damage-associated molecular patterns: Neuroimmunomodulators in central nervous system pathophysiology
- Lactate and lactylation modifications in neurological disorders
- The Regulatory Roles of REST in the Synaptic Development, Function and Related Neurological Disorders
- RNA Therapeutics: Focus on Antisense Oligonucleotides in the Nervous System
- Recent Advances in Visual Dysfunction and Ocular Biomarkers in Neurological Disorders
- Current perspectives on gene therapy and its involvement in curing genetic disorders
- Multi-Scale Temporal Analysis with a Dual-Branch Attention Network for Interpretable Gait-Based Classification of Neurodegenerative Diseases
- PET imaging with [11C]CHDI-00485180-R, designed as radioligand for aggregated mutant huntingtin, in people with Huntington's disease
- The microbial guardians: Unveiling the role of gut microbiota in shaping neurodegenerative disease
- Preclinical evaluation of CHDI-009R for quantification of mutant huntingtin aggregates
- Correction: Pooling of primary care electronic health record (EHR) data on Huntington's disease (HD) and cancer: establishing comparability of two large UK databases
- Potential common pathogenesis of several neurodegenerative diseases
- Durable <em>HTT</em> silencing using non-evolved dCas9 epigenome editors in patient-derived cells
- The orexin/hypocretin system in dementia-related neurological disorders: a double-edged sword in cognitive impairment
- Electrical silencing of dendritic arborization neurons rescues toxic polyglutamine-induced locomotion defect
- Crossing the blood-brain barrier: nanoparticle-based strategies for neurodegenerative disease therapy
- Zebrafish-Based Parkinson's Disease Models: Unveiling Genetic Mechanisms and Therapeutic Pathways
- Stage-Dependent Inhibitory Connectivity in Striatal-Motor Circuit in Huntington's Disease
- From copper homeostasis to cuproptosis: a new perspective on CNS immune regulation and neurodegenerative diseases
- Restoring endogenous Dlg4/PSD95 expression by an artificial transcription factor ameliorates cognitive and motor learning deficits in the R6/2 mouse model of Huntington's disease
- Direct Observation of Secondary Nucleation in Huntingtin Amyloid Formation by High-Speed Atomic Force Microscopy
- Human glial progenitors transplanted into Huntington disease mice normalize neuronal gene expression, dendritic structure, and behavior
- Double strand breaks drive toxicity in Huntington's disease mice with or without somatic expansion
- Epigenetic mechanisms governing cell type specific somatic expansion and toxicity in Huntington's disease
- Modeling Protein Aggregation Kinetics from NMR Data
- The cell-surface shared proteome of astrocytes and neurons and the molecular foundations of their multicellular interactions
- Oligodendroglia in Ageing and Age-Dependent Neurodegenerative Diseases
- Examining the challenges of people living alone with neurodegenerative conditions: a scoping review protocol
- Metabolomics of the Kynurenine Pathway by Laser Desorption Ionization Mass Spectrometry (LDI-MS)
- Anosognosia and avoidant coping do not impact work in early Huntington's disease
- Lowering the HTT1a transcript as an effective therapy for Huntingtons disease
- Anesthetic Management in Huntington's Disease: A Case Report Demonstrating the Effective Use of 2% Hyperbaric Prilocaine for Spinal Anesthesia
- Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease highlight shared and tissue-specific effects
- Brain organoid model systems of neurodegenerative diseases: recent progress and future prospects
- The role of L-DOPA in neurological and neurodegenerative complications: a review
- Concentration-dependent structural transition of huntingtin protein in Huntington's disease
- Unraveling novel mechanisms of ATP-Binding cassette (ABC) transporter in insulin Resistance-induced amyloidogenesis
- Distinct molecular patterns in R6/2 HD mouse brain: Insights from spatiotemporal transcriptomics
- Neuroinflammation to neurodegeneration: Boulevard of broken nerves
- An unusual presentation of Huntington's disease-like syndrome in a patient with Xeroderma pigmentosum type F: Case report and review of the literature
- Exploring the Role of NLRP3 in Neurodegeneration: Cutting-Edge Therapeutic Strategies and Inhibitors
- Multiscale simulations elucidate the mechanism of polyglutamine aggregation and the role of flanking domains in fibril polymorphism
- Navigating the neuronal recycling bin: Another look at huntingtin in coordinating autophagy
- Hung-up reflex: the history of a clinical sign and differential diagnosis
- Health-related quality of life and productivity burden for non-professional caregivers of adults with rare diseases: a real-world study
- SCNT: An R Package for Data Analysis and Visualization of Single-Cell and Spatial Transcriptomics
- The Role of Kinases in Neurodegenerative Diseases: From Pathogenesis to Treatment
- Role of Lysophosphatidic Acid in Neurological Diseases: From Pathophysiology to Therapeutic Implications
- DNA extrusion size determines pathway choice during CAG repeat expansion
- Huntington's Disease-Like 2 in a European Caucasian Patient
- Role of mitochondrial quality control in neurodegenerative disease progression
- A novel 8-octapeptide repeat insertion in PRNP causing Huntington disease-like 1 in a Chinese family: a case report and literature review
- Down-regulation of neuroprotective protein kinase D in Huntingtons disease
- Circular RNAs as disease modifiers of complex neurologic disorders
- Significant underascertainment in Huntington's disease
- Childhood trauma and psychological distress during adulthood in children from Huntington's disease families: An exploratory retrospective analysis
- Goal-directedness deficit in Huntington's disease
- Anti-neurodegenerative treatment in Alzheimer's disease: Multifaceted mechanisms of action of berberine
- KODAMA enables self-guided weakly supervised learning in spatial transcriptomics
- SMURF Reconstructs Single-Cells from Visium HD Data to Reveal Zonation of Transcriptional Programs in the Intestine
- Accurate Quantification of Mutant and Wild-Type polyQ Proteins Using Simple Western Capillary Immunoassays
- Research Progress of G Protein-coupled Receptor 52 on Central Nervous System Diseases
- Preserved Thermoregulation in Huntington's Disease: Insights from an Observational Case-Control Study
- Facilitating DNAzyme transport across the blood-brain barrier with nanoliposome technology
- Unlocking the neuroprotective potential of peptide nucleic acids 5 (PNA5) in neurological diseases: molecular mechanisms to therapeutic approaches
- Modelling Population Genetic Screening in Rare Neurodegenerative Diseases
- Fungal Bioactive Compounds as Emerging Therapeutic Options for Age-Related Neurodegenerative Disorders
- Neural Mechanisms of Object Location Memory in Huntington's Disease
